Society for Clinical Research Sites Announces ICON as New Global Impact Partner

Article

Applied Clinical Trials

The Society for Clinical Research Sites (SCRS), the global trade organization representing the interests of clinical research sites, announced a two-year relationship with ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON will participate as a Global Impact Partner (GIP) and align with 31 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

As a GIP, ICON will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

Read the full release.

 

 

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.